Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: LoLoLoLita who wrote (4322)	1/5/1998 11:29:00 AM
From: Gene Voss	Read Replies (2) \| Respond to of 23519

David:RE <Acceptable Risk> I think your appraisal is correct, deadly diseases should permit more aggressive treatments with greater risk if necessary.I'm not sure any specific criteria exists to equate medical conditions with medical therapy in a generalized way. FDA policy should consider each proposed therapy against a background where patient population, age, specifics of illness to be treated and overall life expectancy without intervention is weighed. Since, this condition is not itself life threatening the proposed therapy should be relatively safe. This is a fairly universal medical concept shared by most physicians. Viagra's position in all this is yet to be determined. GV